Besnier JM - Search Results

1

Opportunistic infections occurring during highly active antiretroviral treatment.

Michelet C, Arvieux C, François C, Besnier JM, Rogez JP, Breux JP, Souala F, Allavena C, Raffi F, Garre M, Cartier F. Michelet C, et al. Among authors: besnier jm. AIDS. 1998 Oct 1;12(14):1815-22. doi: 10.1097/00002030-199814000-00013. AIDS. 1998. PMID: 9792382

2

Efficacy and safety of stavudine and didanosine combination therapy in antiretroviral-experienced patients.

Raffi F, Reliquet V, Auger S, Besnier JM, Chennebault JM, Billaud E, Michelet C, Perre P, Lafeuillade A, May T, Billaudel S. Raffi F, et al. Among authors: besnier jm. AIDS. 1998 Oct 22;12(15):1999-2005. doi: 10.1097/00002030-199815000-00011. AIDS. 1998. PMID: 9814868 Clinical Trial.

3

Long-term assessment of nevirapine-containing highly active antiretroviral therapy in antiretroviral-naive HIV-infected patients: 3-year follow-up of the VIRGO study.

Reliquet V, Allavena C, François-Brunet C, Perré P, Bellein V, Garré M, May T, Souala F, Besnier JM, Raffi F. Reliquet V, et al. Among authors: besnier jm. HIV Med. 2006 Oct;7(7):431-6. doi: 10.1111/j.1468-1293.2006.00402.x. HIV Med. 2006. PMID: 16925728 Free article. Clinical Trial.

4

Stavudine, didanosine and nevirapine in antiretroviral-naive HIV-1-infected patients.

Reliquet V, Ferré V, Hascoet C, Besnier JM, Bellein V, Arvieux C, Molina JM, Breux JP, Zucman D, Rozenbaum W, Allavena C, Raffi F; VIRGO Study Team. Reliquet V, et al. Among authors: besnier jm. Antivir Ther. 1999;4 Suppl 3:83-4. Antivir Ther. 1999. PMID: 16021876 Clinical Trial.

5

The VIRGO study: nevirapine, didanosine and stavudine combination therapy in antiretroviral-naive HIV-1-infected adults.

Raffi F, Reliquet V, Ferré V, Arvieux C, Hascoet C, Bellein V, Besnier JM, Breux JP, Garré M, May T, Molina JM, Perré P, Raguin G, Rozenbaum W, Zucman D. Raffi F, et al. Among authors: besnier jm. Antivir Ther. 2000 Dec;5(4):267-72. Antivir Ther. 2000. PMID: 11142621 Clinical Trial.

6

Intensification of antiretroviral therapy through addition of enfuvirtide in naive HIV-1-infected patients with severe immunosuppression does not improve immunological response: results of a randomized multicenter trial (ANRS 130 Apollo).

Joly V, Fagard C, Grondin C, Descamps D, Yazdanpanah Y, Charpentier C, Colin de Verdiere N, Tabuteau S, Raffi F, Cabie A, Chene G, Yeni P; S 130 Apollo Trial Group. Joly V, et al. Antimicrob Agents Chemother. 2013 Feb;57(2):758-65. doi: 10.1128/AAC.01662-12. Epub 2012 Nov 19. Antimicrob Agents Chemother. 2013. PMID: 23165467 Free PMC article. Clinical Trial.

7

Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults.

Collin F, Duval X, Le Moing V, Piroth L, Al Kaied F, Massip P, Villes V, Chêne G, Raffi F; ANRS CO8 APROCO-COPILOTE study group. Collin F, et al. AIDS. 2009 May 15;23(8):1021-4. doi: 10.1097/QAD.0b013e3283292195. AIDS. 2009. PMID: 19300202 Free PMC article.

8

Is long-term virological response related to CCR5 Delta32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy?

Laurichesse JJ, Taieb A, Capoulade-Metay C, Katlama C, Villes V, Drobacheff-Thiebaud MC, Raffi F, Chêne G, Theodorou I, Leport C; ANRS C08 Aproco-Copilote Study Group. Laurichesse JJ, et al. HIV Med. 2010 Apr;11(4):239-44. doi: 10.1111/j.1468-1293.2009.00769.x. Epub 2009 Dec 28. HIV Med. 2010. PMID: 20050936 Free PMC article.

9

Pregnancy may be followed by an inflexion of the immune reconstitution in HIV-infected women who receive antiretroviral drugs before conception.

Le Moing V, Taïeb A, Longuet P, Lewden C, Delcey V, Drobacheff MC, Chêne G, Leport C; ANRS CO8 (APROCO-COPILOTE) study group. Le Moing V, et al. HIV Med. 2008 Nov;9(10):897-900. doi: 10.1111/j.1468-1293.2008.00641.x. Epub 2008 Sep 14. HIV Med. 2008. PMID: 18795961 Free PMC article.

10

Clinical, biologic, and behavioral predictors of early immunologic and virologic response in HIV-infected patients initiating protease inhibitors.

Le Moing V, Chêne G, Carrieri MP, Besnier JM, Masquelier B, Salamon R, Bazin C, Moatti JP, Raffi F, Leport C; APROCO Study Group. Le Moing V, et al. Among authors: besnier jm. J Acquir Immune Defic Syndr. 2001 Aug 1;27(4):372-6. doi: 10.1097/00126334-200108010-00007. J Acquir Immune Defic Syndr. 2001. PMID: 11468425

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters